title: The orientation of helix 4 in apolipoprotein A-I-containing reconstituted high density lipoproteins.
abstract: The three-dimensional structure of the high density lipoprotein (HDL) component apolipoprotein (apo) A-I and the molecular basis for its protection against coronary artery disease are unknown. In terms of discoidal HDL particles, there has been a debate as to the orientation of the apoA-I alpha-helices around the disc edge. The "picket fence" model states that the alpha-helical repeats, separated by turns, are arranged parallel to the phospholipid acyl chains of the enclosed lipid bilayer. On the other hand, the "belt" model states that the helical segments run perpendicular to the acyl chains. To distinguish between these models, we used nitroxide spin labels present at various depths in the bilayer of reconstituted HDL (rHDL) to measure the position of Trp residues in single Trp mutants of human proapoA-I. Two mutants were studied; the first contained a Trp at position 108, which was located near the center of helix 4. The second contained a Trp at position 115, two turns along the same helix. The picket fence model predicts that these Trp residues should be at different depths in the bilayer, whereas the belt model predicts that they should be at similar depths. Different sized rHDL particles were produced that contained 2, 3, and >4 molecules of proapoA-I per complex. In each case, parallax analysis indicated that Trp-108 and Trp-115 were present at similar depths of about 6 A from the center of the bilayer, consistent with helix 4 being oriented perpendicular to the acyl chains (in agreement with the belt model). Similar experiments showed that control transmembrane peptides were oriented parallel to the acyl chains in vesicles, demonstrating that the method was capable of distinguishing between the two models. This study provides one of the first experimental measurements of the location of an apoA-I helix with respect to the bilayer edge.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0529, USA.
authors.forename: J N
authors.initials: JN
authors.lastname: Maiorano
authors.forename: W S
authors.initials: WS
authors.lastname: Davidson
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D016632:Apolipoprotein A-I / Q000737:chemistry*; D001054:Apolipoproteins A / Q000737:chemistry*; D006801:Humans; D008051:Lipid Bilayers; D008075:Lipoproteins, HDL / Q000737:chemistry*; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010649:Phenylalanine; D010713:Phosphatidylcholines; D011498:Protein Precursors / Q000737:chemistry*; D017433:Protein Structure, Secondary; D013109:Sphingomyelins; D014364:Tryptophan
chemical_list: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D008051:Lipid Bilayers; D008075:Lipoproteins, HDL; D010713:Phosphatidylcholines; D011498:Protein Precursors; D013109:Sphingomyelins; C033171:palmitoylsphingomyelin; D010649:Phenylalanine; D014364:Tryptophan; C028694:1-palmitoyl-2-oleoylphosphatidylcholine